메뉴 건너뛰기




Volumn 13, Issue 5, 2008, Pages 345-357

Preparation and characterization of salt forms of enalapril

Author keywords

Enalapril maleate; Preformulation; Salt; Salt selection

Indexed keywords

BENZENESULFONIC ACID; CITRIC ACID; ENALAPRIL; ENALAPRIL BESYLATE; ENALAPRIL CITRATE; ENALAPRIL MALATE; ENALAPRIL MALEATE; ENALAPRIL MESYLATE; ENALAPRIL TARTRATE; ENALAPRIL TOSYLATE; MALIC ACID; MESYLIC ACID; TARTARIC ACID; TOLUENESULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

EID: 51949100375     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.1080/10837450802244686     Document Type: Article
Times cited : (14)

References (25)
  • 3
    • 0021876419 scopus 로고
    • Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug
    • Anderson BD, Conradi RA. Predictive relationships in the water solubility of salts of a nonsteroidal anti-inflammatory drug. J. Pharm. Sci. 1985;74(8):815-820.
    • (1985) J. Pharm. Sci , vol.74 , Issue.8 , pp. 815-820
    • Anderson, B.D.1    Conradi, R.A.2
  • 6
  • 7
    • 0141523555 scopus 로고
    • Drug excipient interaction study of enalapril maleate using thermal analysis and scanning electron microscopy
    • Cotton ML, Wu DW, Vadas EB. Drug excipient interaction study of enalapril maleate using thermal analysis and scanning electron microscopy. Int. J. Pharm. 1987:40(1-2):129-142.
    • (1987) Int. J. Pharm , vol.40 , Issue.1-2 , pp. 129-142
    • Cotton, M.L.1    Wu, D.W.2    Vadas, E.B.3
  • 8
    • 0034997998 scopus 로고    scopus 로고
    • Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations
    • Omari AMM, Abdelah MK, Badwan AA, Jaber AMY. Effect of the drug-matrix on the stability of enalapril maleate in tablet formulations. J. Pharm. Biomed. Anal. 2001:25(5-6):893-902.
    • (2001) J. Pharm. Biomed. Anal , vol.25 , Issue.5-6 , pp. 893-902
    • Omari, A.M.M.1    Abdelah, M.K.2    Badwan, A.A.3    Jaber, A.M.Y.4
  • 9
    • 51949094659 scopus 로고    scopus 로고
    • Janos F, Bela S, Attila B, Mueller CG, Tamas F, Sandor L, Gabor T. Salts of Enalpril. 2001, WO0132689.
    • Janos F, Bela S, Attila B, Mueller CG, Tamas F, Sandor L, Gabor T. Salts of Enalpril. 2001, WO0132689.
  • 10
    • 51949109486 scopus 로고    scopus 로고
    • ACE inhibitors nitric salts.
    • U.S. Patent 6218417
    • Soldato PD. ACE inhibitors nitric salts. 2001. U.S. Patent 6218417.
    • (2001)
    • Soldato, P.D.1
  • 11
    • 0031806352 scopus 로고    scopus 로고
    • In situ salt screening - a useful technique for discovery support and preformulation studies
    • Tong WQ, Whitesell G. In situ salt screening - a useful technique for discovery support and preformulation studies. Pharm. Dev. Technol. 1998;3(2):215-223.
    • (1998) Pharm. Dev. Technol , vol.3 , Issue.2 , pp. 215-223
    • Tong, W.Q.1    Whitesell, G.2
  • 12
    • 84981573659 scopus 로고
    • A simple method of determining the aqueous solubility of organic substances
    • Fürer R, Geiger M. A simple method of determining the aqueous solubility of organic substances. J. Pharm. Sci. 1976;8(4):337-344.
    • (1976) J. Pharm. Sci , vol.8 , Issue.4 , pp. 337-344
    • Fürer, R.1    Geiger, M.2
  • 13
    • 0000496232 scopus 로고
    • Classifying flow properties of solids
    • Carr RL. Classifying flow properties of solids. Chem. Eng. 1965;72:69-72.
    • (1965) Chem. Eng , vol.72 , pp. 69-72
    • Carr, R.L.1
  • 14
    • 0000496231 scopus 로고
    • Evaluation of flow properties of solids
    • Carr RL. Evaluation of flow properties of solids. Chem. Eng. 1965;72:163-168.
    • (1965) Chem. Eng , vol.72 , pp. 163-168
    • Carr, R.L.1
  • 15
    • 51949116719 scopus 로고    scopus 로고
    • Process for preparing pharmacologically acceptable salt of
    • N-(1(S)-ethoxycarbonyl-3- phenylpropyl)-L-alanyl amino acids. 2002. U.S. Patent 6335453
    • Ueda Y, Kinoshita K, Moroshima T, Yanagida Y, Fuse Y. Process for preparing pharmacologically acceptable salt of N-(1(S)-ethoxycarbonyl-3- phenylpropyl)-L-alanyl amino acids. 2002. U.S. Patent 6335453.
    • Ueda, Y.1    Kinoshita, K.2    Moroshima, T.3    Yanagida, Y.4    Fuse, Y.5
  • 16
    • 1842689072 scopus 로고    scopus 로고
    • Pharmaceutical evaluation of early development candidates "the 100 mg-approach
    • Balbach S, Korn C. Pharmaceutical evaluation of early development candidates "the 100 mg-approach". Int. J. Pharm. 2004;275(1-2):1-12.
    • (2004) Int. J. Pharm , vol.275 , Issue.1-2 , pp. 1-12
    • Balbach, S.1    Korn, C.2
  • 17
    • 51949090874 scopus 로고    scopus 로고
    • ICH Harmonised Tripartite Guideline: Note for guidance on impurities - residual solvents Q3C (R3); 2005. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use http://www.ich.org/LOB/media/MEDIA423.pdf (accessed Nov. 2007).
    • ICH Harmonised Tripartite Guideline: Note for guidance on impurities - residual solvents Q3C (R3); 2005. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use http://www.ich.org/LOB/media/MEDIA423.pdf (accessed Nov. 2007).
  • 20
    • 36549048649 scopus 로고    scopus 로고
    • Applications of X-ray powder diffraction in the pharmaceutical industry
    • Stephenson GA. Applications of X-ray powder diffraction in the pharmaceutical industry. Rigaku J. 2005;22(1):2-15.
    • (2005) Rigaku J , vol.22 , Issue.1 , pp. 2-15
    • Stephenson, G.A.1
  • 21
    • 23444448160 scopus 로고    scopus 로고
    • Characterization of polymorphic solid-state changes using variable temperature x-ray powder diffraction
    • Karjalainen M, Airaksinen S, Rantanen J, Aaltonen J, Yliruusi J. Characterization of polymorphic solid-state changes using variable temperature x-ray powder diffraction. J. Pharm. Biomed. Anal. 2005;39(1-2):27-32.
    • (2005) J. Pharm. Biomed. Anal , vol.39 , Issue.1-2 , pp. 27-32
    • Karjalainen, M.1    Airaksinen, S.2    Rantanen, J.3    Aaltonen, J.4    Yliruusi, J.5
  • 22
    • 19544391084 scopus 로고    scopus 로고
    • Variable-temperature x-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole
    • de Villiers MM, Terblanche RJ, Liebenberg W, Swanepoel E, Dekker TG, Song M. Variable-temperature x-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole. J. Pharm. Biomed. Anal. 2005;38(3):435-441.
    • (2005) J. Pharm. Biomed. Anal , vol.38 , Issue.3 , pp. 435-441
    • de Villiers, M.M.1    Terblanche, R.J.2    Liebenberg, W.3    Swanepoel, E.4    Dekker, T.G.5    Song, M.6
  • 23
    • 0015454626 scopus 로고
    • Elastic recovery and surface area changes in compacted powder systems
    • Armstrong NA, Haines-Nutt RF. Elastic recovery and surface area changes in compacted powder systems. J. Pharm. Pharmacol. 1972;24:135P-136.
    • (1972) J. Pharm. Pharmacol , vol.24
    • Armstrong, N.A.1    Haines-Nutt, R.F.2
  • 24
    • 0037452412 scopus 로고    scopus 로고
    • Determining the compression behavior of pharmaceutical powders from the force-distance compression profile
    • Antikainen O, Yliruusi J. Determining the compression behavior of pharmaceutical powders from the force-distance compression profile. Int. J. Pharm. 2003;252(1-2): 253-261.
    • (2003) Int. J. Pharm , vol.252 , Issue.1-2 , pp. 253-261
    • Antikainen, O.1    Yliruusi, J.2
  • 25
    • 0035013530 scopus 로고    scopus 로고
    • Influence of elastic deformation of particles on Heckel analysis
    • Sun C, Grant DJW. Influence of elastic deformation of particles on Heckel analysis. Pharm. Dev. Technol. 2001:6(2):193-200.
    • (2001) Pharm. Dev. Technol , vol.6 , Issue.2 , pp. 193-200
    • Sun, C.1    Grant, D.J.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.